Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.6 million versus the consensus estimate of $10.25 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.